Spectrum Pharmaceuticals, Inc. Release: ZEVALIN(R) Data to Be Presented at 2008 Annual Meeting of the American Society of Hematology

IRVINE, Calif.--(BUSINESS WIRE)--Spectrum Pharmaceuticals, Inc. (NasdaqGM: SPPI) today announced that ZEVALIN® (ibritumomab tiuxetan) related posters and presentations will be presented at the 50th Annual Meeting of the American Society of Hematology (ASH), December 5-9, 2008 in San Francisco, California.